Hologen is a frontier Gen AI company redefining late-stage drug development. Their Large Medicine Models, trained on exclusive real-world multi-modal NHS clinical data, predict patient-level responses and dramatically improve the success rate of Phase II and III trials, reducing cost, timelines, and failure risk. Hologen. Hologen is based in London and was co-founded with Eric Schmidt to transform the speed, risk and economics of bringing critically important treatments to the patients who need them.